Prostate-specific antigen and its discontents: Why you don’t know whether to screen your patients
OK, we’re going to do another two-part update, because I want to talk about the evolving evidence around prostate cancer screening, and the only thing worse than trying to write about all of that in one sitting would be trying to read what came out. So let’s talk about prostate-specific antigen (PSA), the molecule you […]